David Hipkiss | Executive Chair
AlveoGene
David is a Senior Life Science Professional and Serial Entrepreneur with 18 years of Chair, CEO and CBO leadership experience, coupled to a near 30-year track successful track record of global commercialisation of novel pharmaceutical and biotechnology platforms.
Appearances:
Day 1 - Wednesday 23 October @ 16:10
InGenuITy® - Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy
last published: 11/Oct/24 14:35 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events